Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Integrins

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

Activation of Integrins

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multiscale hierarchical surface structuring of zirconia using femtosecond laser and chemical etching: implications for cell response and antibacterial performance.

Materials today. Bio·2026

Same author

Modulating Integrin and Growth Factor Signaling With Peptides: Strategies to Synergistically Enhance Bone Tissue Regeneration.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Bioactive and degradable PEG hydrogels: A multifunctional approach for tissue regeneration and antibacterial protection.

Biomaterials advances·2025

Same author

Ketenimine Multicomponent Strategy for Multifaceted Amidine Functionalization of Peptides on the Solid Phase.

Angewandte Chemie (International ed. in English)·2025

Same author

Tailoring Cell Behavior and Antibacterial Properties on Zirconia Biomaterials through Femtosecond Laser-Induced Micropatterns and Nanotopography.

ACS applied materials & interfaces·2025

Same author

Peptide Functionalization with Dithioate and Trithioate Groups: A CS<sub>2</sub>-Mediated Solid-Phase Approach.

Organic letters·2025

Search research articles

Related Experiment Video

Updated: May 8, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Tumor Targeting via Integrin Ligands.

Udaya Kiran Marelli¹, Florian Rechenmacher, Tariq Rashad Ali Sobahi

¹Institute for Advanced Study (IAS) and Center for Integrated Protein Science (CIPSM), Department Chemie, Technische Universität München , Garching , Germany.

Frontiers in Oncology

|September 7, 2013

Summary

This summary is machine-generated.

Targeted cancer therapy uses RGD ligands to target tumor cells by binding to integrin receptors. This approach enhances drug delivery and minimizes side effects for improved treatment outcomes.

Keywords:

RGD integrins targeted delivery tumor α5β1 and αvβ6 αvβ3 αvβ5

More Related Videos

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

Published on: August 8, 2019

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

Related Experiment Videos

Last Updated: May 8, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

Published on: August 8, 2019

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

Area of Science:

Biomedical Engineering
Oncology
Drug Delivery Systems

Background:

Selective drug delivery to tumors is crucial for effective cancer therapy and reducing side effects.
Tumor cells often overexpress specific receptors, distinguishing them from normal cells.
Integrin receptors, vital for cell functions, are upregulated on cancer cells.

Purpose of the Study:

To review recent advances in RGD-based integrin ligand presentation for targeted cancer therapy.
To discuss the potential of RGD-targeted drug delivery systems in oncology.

Main Methods:

Review of recent literature on RGD-based integrin ligands.
Analysis of distinct drug delivery systems presenting RGD ligands.
Discussion of RGD-targeted tumor cell delivery strategies.

Main Results:

RGD ligands effectively target integrin receptors overexpressed on tumor cells.
Various drug delivery systems have been developed to present RGD ligands.
RGD-based therapies show promise for selective tumor targeting.

Conclusions:

RGD-based integrin ligands are promising for targeted cancer drug delivery.
Further development of RGD-targeted systems could significantly improve cancer treatment efficacy and safety.